REQUEST A DEMO
Total
USD $0.00
Search more companies

Gen Ilac Ve Saglik Urunleri A.S. (Turkey)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Profile Updated: January 07, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Gen Ilac Ve Saglik Urunleri A.S. is a company in Turkey, with a head office in Ankara. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on August 12, 1997. 450 (2021) employees currently work for Gen Ilac Ve Saglik Urunleri A.S.. From the latest financial highlights, Gen Ilac Ve Saglik Urunleri A.S. reported a net sales revenue increase of 20.12% in 2020. Its’ total assets recorded a growth of 80.3%. The net profit margin of Gen Ilac Ve Saglik Urunleri A.S. increased by 0.96% in 2020.

Headquarters
Daire:2-3 No:3 Mustafa Kemal Mahallesi 2119. Sokak Cankaya
Ankara; Central Anatolia; Postal Code: 06520

Contact Details: Purchase the Gen Ilac Ve Saglik Urunleri A.S. report to view the information.

Website: http://www.genilac.com.tr

Basic Information
Total Employees:
Purchase the Gen Ilac Ve Saglik Urunleri A.S. report to view the information.
Outstanding Shares:
Purchase the Gen Ilac Ve Saglik Urunleri A.S. report to view the information.
Ratings:
Purchase the Gen Ilac Ve Saglik Urunleri A.S. report to view the information.
Incorporation Date:
August 12, 1997
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Subsidiaries
Company Performance
Financial values in the chart are available after Gen Ilac Ve Saglik Urunleri A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
20.12%
Total operating revenue
20.12%
Operating profit (EBIT)
17.61%
Net Profit (Loss) for the Period
34.12%
Total assets
80.3%
Total equity
69.67%
Operating Profit Margin (ROS)
-0.24%
Net Profit Margin
0.96%
Return on Equity (ROE)
-10.79%
Debt to Equity Ratio
-10.61%
Quick Ratio
-1.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?